Healthy Living Washington
SEE OTHER BRANDS

The best health and wellness news from Washington state

Healthy Living Washington: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Washington.

Press releases published on August 20, 2025

Global Hearing Aids Market to Surpass USD 14.42 Billion by 2030 | MarketsandMarkets™

Global Hearing Aids Market to Surpass USD 14.42 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Growing Prevalence of Hearing Loss and Smart Technology Adoption Fuel Sector Expansion The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is projected …

Sai Life Sciences secures SBTi validation for near-term climate targets

Sai Life Sciences secures SBTi validation for near-term climate targets

HYDERABAD, India, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to cut greenhouse …

Healthletic Reports 91% of Users Experience Noticeable Energy Boost with USP-Grade Methylene Blue Formula

Healthletic Reports 91% of Users Experience Noticeable Energy Boost with USP-Grade Methylene Blue Formula

Texas, USA, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Healthletic, a premier U.S.-based wellness supplement manufacturer, today released comprehensive user outcome data revealing that 91% of customers using its Ultimate Methylene Blue drops reported experiencing a …

HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China

HUTCHMED Completes Patient Enrollment of SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the completion of patient enrollment of SANOVO, a China Phase III study of ORPATHYS® ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions